Licenses Patented Alzheimer’s Vaccine

The University of South Florida was granted a patent related to this technology (USPTO # 8,188,046) in 2012, and this patent is exclusively licensed to Alzamend Neuro, a Utah-based pharmaceutical technology company that is dedicated to finding a prevention, treatment and cure for Alzheimer’s disease. The company’s goal is to move this technology out of the research and preclinical stage and into a path toward commercialization.

LINK to Press Release

The post Licenses Patented Alzheimer’s Vaccine appeared first on Alzamend.